Standish Fleming - Profile and Investment Details

Investor Profile

Standish Fleming is a Venture Capital, Incubator, Private Equity Firm based in San Diego, California, United States with a diverse investment portfolio that includes companies such as Altair Therapeutics, Nereus Pharmaceuticals, Morphotek, Concurrent Thinking, NovaCardia, Predix Pharmaceuticals, AGY Therapeutics, Asteres, Conforma Therapeutics, SpotQA, Micromet, Ambit Biosciences, Sequel Pharmaceuticals, Hypnion, Imagine Pharmaceuticals, Gryphon Therapeutics, Acorda Therapeutics, Tioga Pharmaceuticals, Cabrellis Pharmaceuticals, Adiana, Affinium Pharmaceuticals, Dynavax Technologies, Proprius Pharmaceuticals, Sanarus MedicalTargeGen, Viracta Therapeutics, LigoCyte Pharmaceuticals, Syndax Pharmaceuticals, Kemia, . Over time, Standish Fleming has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Standish Fleming is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Wellness, Life Science, Engineering, Portfolio Management, Medical Technologies, Information Services, Information Technology (IT), Mobile, Software, Biotechnology, Drug Development, Sourcing, Clinical Trials, Web Development, Medical, B2B, Therapeutics, Media and Entertainment, Pharmaceuticals, Application Performance Management, Acquisitions may find it worthwhile to explore potential connections with Standish Fleming, as their portfolio suggests a familiarity and interest in this area.

Understanding Standish Fleming’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.